Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology
Michael Benatar, Joanne Wuu, Edward D. Huey, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 6, pp. 364-376
Open Access | Times Cited: 12

Showing 12 citing articles:

Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis
Samir Abu‐Rumeileh, Leila Motlagh Scholle, Alexander Mensch, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Ternary mixed enzyme pretreatment combined with microwave-assisted hydrodistillation for extracting essential oil from fresh Acanthopanax trifoliatus (L.) Merr. stems: enhancement of yield and biological activity
Qingfen Zhang, Xinyang Gao, Shiyu Yang, et al.
Journal of Applied Research on Medicinal and Aromatic Plants (2025), pp. 100622-100622
Closed Access | Times Cited: 1
Tofersen and other antisense oligonucleotides in ALS
Albert Ludolph, Maximilian Wiesenfarth
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access | Times Cited: 1
Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders
Azhagu Madhavan Sivalingam, Darshitha D Sureshkumar
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217
Breton M. Asken, Rosie E. Curiel, Elizabeth Crocco, et al.
The Journal of Prevention of Alzheimer s Disease (2025) Vol. 12, Iss. 1, pp. 100011-100011
Open Access
Spatial Transcriptomics: Biotechnologies, Computational Tools, and Neuroscience Applications
Qianwen Wang, Hong-Yuan Zhu, Linhong Deng, et al.
Small Methods (2025)
Closed Access
Exploring CSF biomarkers in amyotrophic lateral sclerosis: Highlighting the significance of TDP-43
Yih-Chih Kuo, Chih-Chao Yang, Li‐Kai Tsai
Journal of the Neurological Sciences (2025), pp. 123479-123479
Closed Access
Metabolic alterations in the absence of a detectable neuromuscular phenotype in novel genomically humanisedSOD1A4Vmice.
David Thompson, Chloe Williams, Andrew P. Tosolini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Amyotrophic lateral sclerosis caused by SOD1 variants: from genetic discovery to disease prevention
Michael Benatar, Janice Robertson, Peter M. Andersen
The Lancet Neurology (2024) Vol. 24, Iss. 1, pp. 77-86
Closed Access | Times Cited: 3
Genetic testing for monogenic forms of motor neuron disease/amyotrophic lateral sclerosis in unaffected family members
Jade Howard, Amina Chaouch, Andrew G. L. Douglas, et al.
European Journal of Human Genetics (2024)
Open Access | Times Cited: 2
Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD
Michael Benatar, Terry Heiman‐Patterson, Johnathan Cooper‐Knock, et al.
Journal of Neurology Neurosurgery & Psychiatry (2024), pp. jnnp-334339
Open Access | Times Cited: 2
DNA methylation in amyotrophic lateral sclerosis: where do we stand and what is next?
Fabio Coppedè
Epigenomics (2024), pp. 1-12
Closed Access | Times Cited: 1
Trial designs for motor neuron disease in the 21st century
Steve Vucic
The Lancet Neurology (2024)
Closed Access
Page 1

Scroll to top